Leadership Team

Roy Jensen, MD Director, KU Cancer Center CEO, Midwest Cancer Alliance	Shrikant Anant, PhD Associate Director, Basic Science
Terance T. Tsue, MD, FACS Vice President and Physician-in-Chief, The University of Kansas Cancer Center	Teresa Christenson Associate Director Administration
Dan Dixon, PhD Co-Leader, Cancer Prevention and Survivorship	Edward Ellerbeck, MD, MPH Co-Leader, Cancer Control and Population Health
Gary Doolittle, MD Medical Director, Midwest Cancer Alliance	Carol Fabian, MD Associate Director, Clinical Research
Alan Gamis, MD Co-Leader, Drug Discovery, Delivery and Experimental Therapeutics Program	Andrew Godwin, PhD Deputy Director, The University of Kansas Cancer Center Director, Biospecimen Repository
Jennifer Klemp, PhD Co-leader, Cancer Prevention and Survivorship Program	Linheng Li, PhD Co-leader, Cancer Biology
Sally Maliski, PhD Associate Director, Equity	Matthew Mayo, PhD Associate Director, Shared Resources
Kristi Neufeld, PhD Co-Leader, Cancer Biology	Danny Welch, PhD Associate Director, Education
Jeffrey Reene, MBA Chief Operating Officer	Scott Weir, PharmD, PhD Associate Director, Translational Research; Director, Institute for Advancing Medical Innovation
Christie Befort, PhD Co-leader, Cancer Control & Population Health	Steve Williamson, MD Director, Early-Phase Program, Clinical Research
Weijing Sun, MD Division Director, Medical Oncology; Associate Director for Clinical Research	Tara Lin, MD Medical Director, Clinical Trials Office
John Taylor, MD, MS Co-leader, Drug Discovery, Delivery and Experimental Therapeutics